Related Experiment Video

Updated: Aug 8, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Chlamydia pneumoniae antibody levels before coronary events in the Helsinki Heart Study as measured by different

Mika Paldanius1, Maija Leinonen, Hanna Virkkunen

  • 1National Public Health Institute, P.O. Box 310, FIN-90101 Oulu, Finland. mika.paldanius@ktl.fi

Diagnostic Microbiology and Infectious Disease
|June 8, 2006
PubMed

Insights

Microimmunofluorescence (MIF) is the gold standard for detecting Chlamydia pneumoniae antibodies, outperforming enzyme immunoassay (EIA). High IgA MIF titers at baseline predict coronary events, highlighting MIF

Area of Science:

  • Immunology
  • Cardiovascular Disease Epidemiology
  • Infectious Disease Diagnostics

Background:

  • Chronic Chlamydia pneumoniae infection diagnosis lacks specific tests.
  • Enzyme immunoassay (EIA) is often used, but microimmunofluorescence (MIF) is the gold standard for C. pneumoniae antibody measurement.
  • The predictive value of C. pneumoniae antibody levels for coronary events needs further investigation.

Purpose of the Study:

  • To assess the predictive values of C. pneumoniae antibody levels and seroconversions for coronary events.
  • To compare the diagnostic performance of MIF and EIA in predicting cardiovascular outcomes.
  • To validate MIF as the gold standard in the context of coronary event prediction.

Main Methods:

  • Prospective Helsinki Heart Study cohort utilized.
  • Sera from coronary event cases and controls analyzed at baseline and follow-up.
  • Conditional logistic regression analysis applied to assess antibody levels and seroconversions measured by MIF and EIA.

Main Results:

  • Agreement between MIF and EIA antibody levels was highest at high titers.
  • High IgA MIF titers (>/=40) at baseline significantly predicted future coronary events.
  • MIF seroconversion showed a non-significant increased risk for coronary events.

Conclusions:

  • Microimmunofluorescence (MIF) remains the gold standard for C. pneumoniae antibody measurement.
  • High baseline IgA MIF titers are predictive of future coronary events.
  • Differences in antibody kinetics between EIA and MIF support MIF's superior diagnostic utility.

More Related Videos

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...